# Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature

> **NCT01201551** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 40 (actual)

## Conditions studied

- Primary Vascular Dysregulation

## Interventions

- **DRUG:** Brimonidine
- **DRUG:** Latanoprost
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01201551
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01201551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01201551, "Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01201551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*